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Protease  stimulation  in cultured  normal  human  epidermal  keratinocytes  (NHEK)  due  to  sulfur  mustard
(SM)  exposure  is  well  documented.  However,  the  speciﬁc  protease(s)  stimulated  by  SM  and  the  protease
substrates  remain  to  be  determined.  In this  study,  we  observed  that SM stimulates  several  proteases  and
the epidermal-dermal  attachment  protein  laminin-5  is one  of  the  substrates.  We  propose  that  following
SM  exposure  of the skin,  laminin-5  degradation  causes  the  detachment  of  the  epidermis  from  the  der-
mis  and,  therefore,  vesication.  We  utilized  gelatin  zymography,  Western  blotting,  immuno-ﬂuorescence
staining,  and  real-time  polymerase  chain  reaction  (RT-PCR)  analyses  to  study  the  SM-stimulated  pro-
teases  and  laminin-5  degradation  in  NHEK.  Two  major  protease  bands  (64 kDa  and 72 kDa) were  observed
by  zymography  in  SM-exposed  cells.  Addition  of serine  protease  inhibitor  (aprotinin,  100  M),  or  the
metalloprotease  inhibitor  (amastatin,  100  M)  to NHEK  cultures  prior  to SM  exposure  decreased  the
SM-stimulated  protease  bands  seen  by  zymography.  These  inhibitors  completely  or partially  prevented
SM-induced  laminin-5  2 degradation  as seen  by Western  blotting  as well  as immuno-ﬂuorescence  stain-
ing. Our  results  from  Western  blotting  and  RT-PCR  studies  also  indicated  that the  membrane-type  matrix
metalloproteinase-1  (MT-MM-1)  may  be involved  in SM-induced  skin  blistering.
To  summarize,  our results  in  the  NHEK  model  indicate  the  following:  (a) SM  stimulates  multiple  pro-
teases  including  serine  protease(s),  and  metalloproteases;  (b)  SM decreases  the  level  of  laminin-5  2,
which  is  prevented  by either  a  serine  protease  inhibitor  or a metalloprotease  inhibitor  and  (c)  MT-MMP-1
maybe  one  of the  proteases  that  is involved  in skin  blistering  due to SM  exposure.
©  2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Protease stimulation in epidermal keratinocytes and at
he epidermal-dermal junction is one of the mechanisms of
M-induced vesication [1] SM-stimulated proteases cause the sep-
ration of the epidermis from the dermis by degrading attachment
roteins such as laminin-5 [2]. The use of protease inhibitors is one
f the several pharmacological approaches currently under con-
ideration as vesicant medical countermeasure. In this context, the
xperiments done at the USAMRICD led to two critical observations
hat (a) in the mini pig skin, which is more akin to the human skin,
nly one protein in the lamina lucida area i.e., laminin is affected
y sulfur mustard [1], and (b) in human skin explants, laminin-
∗ Corresponding author.
E-mail address: xiannu.jin.ctr@mail.mil (X. Jin).
ttp://dx.doi.org/10.1016/j.toxrep.2016.03.007
214-7500/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
5 immunoreactivity is decreased by SM [1]. A defect in laminin-5
subunit composition, especially 3 and 2, has been implicated in
a human blistering disease at the level of lamina lucida [3].
The role of proteolysis in SM vesication has been indicated
by the results from some experimental studies including those
using the skin in the SM-exposed mouse ear model [4,5]. Both
in vitro and in vivo studies by Cowan et al. [6] indicated that
serine protease inhibitors could protect against vesication caused
by the blistering agent, Chakrabarti et al. [7] reported from
studies using cultured normal human epidermal keratinocytes
(NHEK) model that both the amount of membrane bound pro-
tease and its proteolytic activity were stimulated following
exposure to SM.  These SM effects were inhibited by a Ca(2+)
chelator, either 2 mM EGTA (ethylene glycol-bis(amino ethyl
ether)N,N,N′,N′ tetraacetic acid) or 50 microM BAPTA-AM (1,2-bis
(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis ace-
toxymethyl ester). A protein puriﬁcation study by Ray et al. [8]
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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sing cultured NHEK model and gel exclusion/hydrophobic chro-
atography showed that a 70–80 kDa protease was  stimulated
y SM;  this SM-stmulated protease had an amino acid sequence
omologous with a mammalian-type bacterial serine endopep-
idase. However, there was no direct monitoring and matching
f the proteases stimulated by SM.  Based on these observations,
dentifying the protease(s) stimulated by SM in NHEK and further
etermining their inhibitors may  provide important information to
valuate prospective antivesicant drugs.
Zymography analysis of culture medium conditioned by guinea
ig tracheal epithelial cells demonstrated that these cells pro-
uced 92 kDa gelatinase on exposure to SM [9]. However, Mol  et al.
eported that the secretion of matrix metalloprotease-9 (MMP-9)
n NHEK and skin was decreased following SM exposure. On the
ontrary, the release of MMP-2 from skin pieces and the release of
MP-3 from cultured NHEK were increased following exposure to
oderate concentrations of SM,  but suppressed following exposure
o higher concentrations of SM [10]. Previously, we  puriﬁed and
artially characterized a single protease that hydrolyzes laminin
n vitro [7]. These ﬁndings strongly suggest that some speciﬁc pro-
ease(s) may  be responsible for SM-induced vesication involving
aminin-5 degradation.
This concept of a speciﬁc protease being involved in SM pathol-
gy is important because the use of generalized protease inhibitors
n preventing SM toxicity may  be contraindicated due to a sys-
emic toxicity concern. However, no systematic study has been
arried out so far to study and to characterize the types of pro-
eases stimulated by SM and their inhibitors. Here, we  utilize
elatin zymography, Western blotting, immunoﬂuorescence stain-
ng technique, and RT-PCR to explore and to characterize the
M-stimulated proteases and also laminin-5 degradation in cul-
ured NHEK exposed to SM.  The purpose of this study was to
stablish new technologies and to obtain new knowledge required
o identify the speciﬁc SM-stimulated protease(s), the logical func-
ions, and the inhibitors.
. Materials and methods
.1. Materials
Normal human epidermal keratinocytes (NHEK), human ker-
tinocyte growth supplement (Insulin, BPE, Transferrin, EGF,
ydrocortisone, PSA), and basal media for epithelial cells—Epilife
ith calcium, kit for splitting cells were purchased from Cascade
iologics (Portland, OR). Sulfur mustard (>98% pure) was from
he Edgewood Chemical and Biological Center (ECBC), Aberdeen
roving Ground, Maryland. Protein molecular weight markers,
ymogram gel, zymogram renaturing and developing buffers,
recast SDS-PAGE gels and buffers were from Invitrogen (Carls-
ad, CA). Anti-laminin-5 2 polyclonal antibody and horseradish
eroxidase-conjugated secondary goat antibody were from Santa
ruz (Santa Cruz, CA). Enhanced chemiluminescence (ECL) detec-
ion reagent was from Amersham (Piscataway, CA). Protease
nhibitor cocktail, chromozym TRY (serine speciﬁc substrate), and
protinin were from Roche (Basel, Switzerland). Amastatin was
urchased from Axxora, LLC (San Diego, CA). Dimethyl sulfox-
de (DMSO), coomassie blue R-250, and E-64 were from Sigma
St. Louis, MO). Anti-membrane type matrix metalloptotease-1
ntibody (MT-MMP-1), anti-matrix metalloprotease-2 antibody
MMP-2), and anti-matrix metalloprotease-9 (MMP-9) antibody
ere from Research Diagnostics, Inc. (Flanders, NJ).rts 3 (2016) 393–400
2.2. NHEK culture and exposure to SM
NHEK cultures were initiated in basal media from frozen stock
(passage 2, P2) using 0.2 × 106 cells per 75 cm2 plastic tissue cul-
ture ﬂasks. Cells were grown at 37 ◦C in a humidiﬁed atmosphere
of 95% air/5% CO2 according to the method described by Rhoads
et al. [11]. When cells became approximately 80% conﬂuent in the
ﬂasks, the cells were sub cultured to passage 3 (P3) to be used in
experiments. Treatment of cells with 200 M sulfur mustard was
carried out according to the method described by Broomﬁeld and
Gross [12]. Cells were exposed to desired SM concentrations using a
formulation originally described by Broomﬁeld and Gross [12] and
by a method as described by Ray et al. [13]. The stock SM formula-
tion consisted of a frozen binary mixture of 5 l undiluted SM (oil)
and 10 ml  aqueous culture medium. The frozen SM Stock was kept
on ice until cell exposure. Just prior to cell exposure, the stock was
thawed and immediately vortexed hard at room temperature for
1 min  to make a SM solution in the medium. Appropriate dilutions
were made as quickly as possible for exposure of the cells by adding
aliquots of stock SM solution to cells. Cells were exposed to this SM
concentration because this was considered to be the in vitro equiva-
lent to an in vivo vesicating concentration of SM.  Protease inhibitors
were dissolved in DMSO reagent, and then further diluted in NHEK
culture medium. Protease inhibitor studies were conducted using
about 80% conﬂuent NHEK cultures and the inhibitor was added
to cell cultures 30 min  prior to cell exposure to 200 M SM.  Each
experiment was  repeated at least three times or more times to test
the statistical signiﬁcance of the data obtained.
2.3. Zymography
Gelatin zymography was  conducted by electrophoresis as
described by Heussen and Dowdle [14]. Cell lysates were pre-
pared 16–18 h after SM exposure in Mammalian Protein Extraction
Reagent (PIERCE, Rockford, IL). Protein concentration was  deter-
mined with the BCA Protein Assay Kit (PIERCE, Rockford, IL). Cell
lysates were normalized to equal protein concentration. A 50 g
protein equivalent of each sample was lyophilized and mixed with
20 l Novex Tris-Glycine SDS sample buffer (2×)  in the absence
of reducing agent, and incubated for 10 min  at room tempera-
ture. The samples were electrophoresed on zymogram gel (10%
polyacrylamide gels co-polymerized with 1 mg/ml  gelatin). After
electrophoresis, the gels were incubated in zymogram renaturing
buffer containing 2.5% Triton-100 with gentle agitation for 30 min
at room temperature and then incubated in zymogram developing
buffer for 30 min  followed by changing to fresh zymogram devel-
oping buffer and incubation at 37 ◦C overnight. After incubation,
the gels were stained with 0.5% Coomassie Brilliant Blue R-250
and de-stained with de-staining solution (40% methanol, 10% acetic
acid in distilled water). Protease activities were detected as clear
bands against a dark blue background of Coomassie-Blue R-250
stained gelatin. For inhibition studies, 100 M amastatin [15,16],
and 100 M aprotinin [17,18] were added to ﬂasks followed by
200 M SM exposure. The inhibitory activity of each compound
was ascertained by comparing the thickness of the gelatinolytic
bands in gels developed in the presence or absence of inhibitors.
2.4. Protein elution from gels with Bio-Rad Model 422
electroeluter
Clear protease bands were cut from zymogram gels into 3 mm2
pieces and each piece was  separately placed in electroeluter glass
tubes. Each tube was  ﬁlled not past the half-way point. 1 l of the elu-
tion buffer (25 mM tris base, 192 mM glycine, 0.1% SDS) was added
in the tubes and the elution was  carried out at 10 mA/tube for 4–5 h
using the Bio-Rad Model 422 electroeluter. After elution, the upper
y Reports 3 (2016) 393–400 395
(
o
c
o
2
ﬁ
e
[
o
u
3
i
4
a
f
2
0
2
4
g
1
t
c
P
t
a
b
w
o
w
d
c
u
2
t
i
b
ﬁ
b
1
a
c
a
t
t
s
2
c
i
c
A
t
s
C
Fig. 1. Zymography of untreated (no SM)  control NHEK and 200 mM SM-exposed
NHEK extracts. Cell extracts were prepared as described under Methods at 16–18 h
after SM exposure. Enhanced protease bands at both 72 kDa and 64 kDa protein
molecular weight regions on the gel indicated SM-induced protease stimulation inX. Jin et al. / Toxicolog
elution) buffer was removed from each glass tube down to the level
f the frit. The adapter and cap were removed and the eluate was
arefully recovered by aspiration. The cap was rinsed with 200 l
f fresh elution buffer and the solution was added to the eluate.
.5. Chromozym TRY assay
Synthetic substrate was used to determine the substrate speci-
city of the puriﬁed enzyme. Protease activity in eluate from
lectroeluter was assayed according to method by Cowan et al.
19] using 50 l Chromozym TRY as substrate. The total volume
f the reaction mixture was 100 l in which 50 l of eluate was
sed as the enzyme source. The reaction was carried out for 2 h at
7 ◦C and stopped by incubating on ice for 10 min. Enzyme activ-
ty was measured by reading the reaction mixture absorbance at
05 nm.  Trypsin standard was used instead of the puriﬁed enzyme
s positive control. The assay can detect protease at a ng/ml level,
or example, 50 l of 100 g/ml of trypsin assayed with 50 l of
.5 mM Chromozym TRY substrate for 2 h yielded an absorbance of
.602 ± 0.036 at 405 nm.
.6. Western blotting analysis
NHEK lysates were normalized to 20 g protein and mixed with
× SDS sample buffer and loaded onto 4–12% NuPAGE Bis-Tris
els, and then subjected to electrophoresis at constant voltage of
25 V for about 90 min. After electrophoresis, the proteins were
ransferred to a polyvinylidence diﬂuoride (PVDF) membrane at a
onstant voltage of 30 V for about 90 min. Blots were blocked in
BS blocking buffer with 5% non-fat milk overnight at 4 ◦C, and
hen incubated with primary antibodies for 1 h at room temper-
ture followed by washing 5 min  each three times with washing
uffer (0.05% Tween-20 in PBS solution). Then the membranes
ere incubated with a horseradish peroxidase-conjugated sec-
ndary antibody for 1 h followed by washing 5 min  each three times
ith washing buffer (0.05% Tween-20 in PBS solution). The signal
etection of Western blotting was performed by using enhanced
hemiluminescence (ECL) kit. Image analysis was performed by
sing Bio-Rad Quantity One software.
.7. Immunoﬂuorescence staining
Laminin-5 distribution and degradation, and the effect of pro-
ease inhibitors on laminin-5 2 degradation were determined by
mmunoﬂuorescence staining using laminin-5 2 primary anti-
ody. Brieﬂy, NHEK were cultured in chamber slides for 3–4 days,
xed in 3.7% para-formaldehyde solution, washed with phosphate
uffered saline (PBS), and blocked with 5% normal goat serum for
 h at room temperature, followed by 1 h incubation with a primary
ntibody. After washing 5 min  each 3 times, the Rhodamine-
onjugated secondary antibody against goat IgG was  added for 1 h
t room temperature and then the slides were washed with PBS 3
imes for 5 min  each. The slides were mounted with mounting solu-
ion (SIGMA). The cells were viewed with a Bio-Rad laser confocal
ystem attached to an Olympus microscope.
.8. Real-time quantitative reverse transcription-polymerase
hain reaction (RT-PCR)
Total RNA was prepared from NHEK at the end of the exper-
ments. Brieﬂy, the cells were washed once with ice-cold PBS,
ollected by trypsinization and stored in RNAlater® (Ambion,
ustin, TX) at −20 ◦C until use. Upon thawing of the frozen cells,
otal RNA was puriﬁed using the RNAqueous® kit (Ambion). First-
trand cDNA was synthesized from 5 g total RNA using the High
apacity cDNA Archive kit® (Applied Biosystems, Foster City, CA).the  NHEK model.
Of each 100 l cDNA reaction, 9 l was used in 20 l reactions
for human cDNA-speciﬁc TaqMan Gene Expression assays for MT-
MMP-1 and -actin (Applied Biosystems). All assays were carried
out in a 96-well format. Real-time ﬂuorescent detection of PCR
products was  performed using an Applied Biosystems Prism 7500
System using the following thermocycling conditions: 1 cycle of
50 ◦C for 2 min  and 95 ◦C for 10 min; 50 cycles of 95 ◦C for 15 s
and 60 ◦C for 1 min  -actin was used as a control for endogenous
gene expression. All samples were run in duplicate, and ampliﬁ-
cation data were analyzed using Applied Biosystem’s Fast System
Sequence Detection Software, version 1.3. Relative quantiﬁcation
was calculated according to the Ct method (Applied Biosys-
tems) using a statistical conﬁdence of 99.9%.
2.9. Statistical analysis
Comparisons to detect signiﬁcant differences were made using
student’s t-test with p < 0.05.
3. Results
3.1. Zymogram analysis for proteases
Gelatin zymogram of the untreated (no SM) control NHEK
showed that small amounts of proteases, mainly as 72-kDa and
64 kDa. Increased intensities of both 72 kDa and 64 kDa protease
bands were observed in SM-exposed NHEK (Fig. 1).
3.2. Prevention of SM-induced protease stimulation by inhibitors
of both serine protease and metalloprotease
Addition of a serine protease inhibitor, aprotinin (100 M)  to
NHEK 30 min  prior to 200 M SM exposure abolished the SM
stimulated 72 kDa band (Fig. 2A). Addition of a metalloprotease
inhibitor, amastatin (100 M)  30 min  prior to 200 M SM exposure
decreased the 64 kDa protease bands (Fig. 2B). However, a cysteine
protease inhibitor, N-[N-(l-3-trans-carboxyoxyrane-2-carbonyl)-
l-leucyl]-agmatine (E-64, 100 M),  did not decrease 72 kDa or
64 kDa band stimulated by SM (data not shown). These results
indicated the roles of both serine protease and metalloprotease in
protease stimulation due to SM in NHEK.
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Fig. 2. Reduction of SM-induced protease stimulation by pretreatment with protease inhibitors prior to SM exposure in NHEK. Either the serine protease inhibitor, Aprotinin
(100  mM;  panel A) or the metalloprotease inhibitor, Amastatin (200 mM;  panel B) was  added to NHEK cultures 30 min  prior to 200 mM SM exposure. Zymographic analyses
of  protease stimulation were conducted using cell extracts prepared at 16–18 h after SM exposure. Both Aprotinin and Amastatin prevented SM-induced protease stimulation
at  72 kDa and 64 kDa zones, respectively in gelatin zymograms.
Fig. 3. Prevention of SM-induced laminin-5 2 degradation in NHEK by protease inhibitors as shown by Western blotting. Cells were treated with respective protease
inhibitors 30 min  prior to 200 M SM exposure. Prevention of laminin-5 g2 degradation was noticed with 100 M of aprotinin (A) or 100 mM amastatin (B). Both the immune
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fter  SM exposure were statistically signiﬁcant (** means P < 0.05) compared to SM a
eparate experiments done at three different times.
.3. Prevention of SM-induced laminin-5 degradation in NHEK by
rotease inhibitors as shown by Western blotting
Laminin-5 degradation was measured at 16 h after 200 M SM
xposure in NHEK. Pretreatment of NHEK cultures with either
he serine protease inhibitor, aprotinin (100 M, Fig. 3A) or
he metalloprotease inhibitor, amastatin (100 M,  Fig. 3B) pre-
ented laminin-5 2 degradation. However, the cysteine protease
nhibitor, E-64 (100 M)  had no effect (data not shown).
.4. Prevention of SM-induced laminin-5 degradation in NHEK by
rotease inhibitors as shown by immunoﬂuorescence staining
Immunoﬂuorescence staining of NHEK with anti-laminin-5 2
ntibody showed SM (200 M)-induced laminin-5 2 degradation
t 16 h after SM exposure; this was prevented by pretreatment
f NHEK cultures with either the serine protease inhibitor, apro-
inin (100 M,  Fig. 4A) or the metalloprotease inhibitor, amastatin
100 M,  Fig. 4B). However, the cysteine protease inhibitor E-64
100 M)  had no effect (Fig. 4C).re shown here. Prevention of laminin-5 g2 degradation by aprotinin or amastatin
he average laminin-2 2 levels (% of control) and error bars are from three repeated
3.5. Analysis of 72 kDa protease band by chromozym TRY
The 72 kDa bands from SM-exposed and unexposed NHEK
extracts were cut, electro-eluted and determined for protease
activity by the chromozym TRY (substrate for serine proteases)
method. It was  found that 72 kDa serine protease activity was
increased by 2.5 fold in the SM treated group compared to the
untreated group (Fig. 5). Increased numbers in A405 means that
protease activity was increased with SM-exposure in electro-eluted
NHEK samples.
3.6. Characterization of matrix metalloprotease(s) by Western
blotting analysis
Western blotting technique was used to characterize and ana-
lyze matrix metalloproteases. Cell lysates were normalized to
20 g protein and were subjected to Western blotting analyses. An
increase in MT-MMP-1 was  detected; however, no change in MMP-
2 and a decrease in MMP-9 were observed (Fig. 6). MT-MMP-1
appeared as 64 kDa protein band, and matched with our zymogram
X. Jin et al. / Toxicology Reports 3 (2016) 393–400 397
Fig. 4. Prevention of laminin-5 2 degradation in NHEK by protease inhibitors as shown by immunoﬂuorescence staining. Immunoﬂuorescence staining with anti laminin–5
2  antibody revealed that degradation of laminin-5 2 seen at 16-h after 200 mM SM expo
with  either the serine protease inhibitor, aprotinin (100 M)  (A), or the metalloprotease i
The  images were representatives of 10 viewed ﬁelds.
Fig. 5. Chromozym TRY assay of protein eluates for SM-exposed and unexposed
control NHEK. The 72 kDa bands in gelatin zymograms using SM-exposed and unex-
posed control cell extracts were cut, electro-eluted and assayed for protease activity
by  the Chromozym TRY. Protease activity was increased by 2.5 fold at 16 h after
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iM (200 M) exposure compared with unexposed control cells. The protease activ-
ty  after SM exposure was  statistically signiﬁcant (** means P < 0.05) compared to
ontrol.
esult. Moreover, this 64 kDa band was blocked by the matrix met-
lloprotease inhibitor, amastatin further conﬁrming that this was
 metalloprotease.
.7. MT-MMP-1 mRNA expressionTo determine whether the change in the expression level of MT-
MP-1 shown in Fig. 6A was due to a change in the MT-MMP-1
RNA level, MT-MMP-1 mRNA was measured by real-time RT-PCR
n NHEK at 16 h after SM exposure. MT-MMP-1 mRNA expres-sure was  prevented by pretreatment of NHEK cultures 30 min prior to SM exposure
nhibitor, amstatin (100 M)  (B), the cysteine protease inhibitor E-64 (100 M)  (C).
sion in SM-exposed NHEK was increased by about seven-fold over
the unexposed control cells (Fig. 7). These data suggested that the
increase in MT-MMT-1 protein expression with SM-exposure in
NHEK was mainly due to transcriptional regulation.
4. Discussion
Enhanced protease activity following SM exposure in NHEK
demonstrated that the alkylating agent, SM can cause protease
stimulation in cells. Cultured NHEK have been used as an in vitro
experimental model of cell death and vesication due to SM [20]. In
the present study, zymographic analyses showed that at least two
different types of proteases were elevated in lysates of cells treated
with SM and these increases were blocked by protease inhibitors
such as a metalloprotease inhibitor, amastatin and a serine protease
inhibitor, aprotinin. Western blotting showed that SM (200 M)-
exposed NHEK had a decreased level of laminin-5 content and this
decrease was prevented by pretreatment of NHEK cultures with a
protease inhibitor, amastatin or aprotinin 30 min  prior to SM expo-
sure. Immunoﬂuorescence staining indicated that the degradation
of laminin-5 2 due to SM exposure in NHEK was also blocked by
protease inhibitor treatment 30 min  prior to SM exposure. These
results implied that proteases like serine protease(s) and metallo-
protease(s) are induced or activated by SM exposure in NHEK. These
proteases may  cause the degradation of laminin-5 in SM-exposed
NHEK and consequently epidermal-dermal separation and, there-
fore, vesication.Previous reports in the literature had shown SM-induced stimu-
lation of protease in cultured NHEK and had proposed its role in skin
blistering due to SM,  but which type of protease is involved in blis-
tering remained controversial. In contrast to the previous studies
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Fig. 6. Detection of MT-MMP-1 after SM exposure in NHEK by Western blotting analysis. Increase of MT-MMP-1 was detected after 200 mM SM exposure compared to
unexposed control NHEK, and MT-MMP-1 band was  inhibited by adding 100 M amastatin (metalloprotease protease inhibitor) 30 min prior to SM exposure (A). There was
n osure in NHEK. The changes in MT-MMP-1 and MMP-9 after SM exposure with amastatin
p  or amastatin alone. The average of each protease level (% of control) and error bars were
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Fig. 7. RT-PCR analysis of MT-MMP-1 mRNA level. MT-MMP-1 mRNA expression
increased by about seven-fold in SM (200 M)-exposed NHEK over that in unex-
posed control cells at 16 h after SM exposure. These data suggested that the increase
in MT-MMP-1 protein expression with SM-exposure in NHEK was  mainly due to
transcriptional regulation. The change in MT-MMP-1 after SM exposure was statis-
tically signiﬁcant (** means P < 0.05) compared to untreated control. The averageo  change in MMP-2 level (B), but a decrease in MMP-9 level (C) at 16 h after SM exp
retreatment were statistically signiﬁcant (** means P < 0.05) compared to either SM
rom  three or more separate experiments.
9,21], the ﬁndings from the current study suggested that serine
rotease(s) alone or metalloprotease(s) alone might not be able
o completely degrade the epidermal-dermal matrix components,
hereby leading to skin blistering. Our results indicated that both
ypes of proteases, serine protease and metalloprotease, may  play
 role in blistering due to SM.  This contributes to the hypothesis
f the role of proteolysis in SM vesication, and thus extends the
hysiological implications for an antivesicant drug development
pproach.
It was proposed that serine protease inhibiters could delay and
rotect skin from vesication caused by SM [22]. Non-reducing
–12% SDS gel electrophoresis of cell extract from SM-exposed
HEK revealed a mustard-stimulated protein band at about
0–80 kDa that was associated with protease activity; this was
nhibited by adding EGTA, BAPTA, DFP or cycloheximide in NHEK
ulture prior to SM exposure [23]. These results implicated that
he SM-stimulated protease could be a calcium-dependent ser-
ne protease. Another group reported a complete inhibition of SM
ncreased proteolysis in NHEK by using protease inhibitors such
s antipain, leupeptin, and 4-(2-aminoethyl)-benzenesulfonylfonyl
uoride) [24]. These data also suggested that serine protease was
nduced by SM treatment. In the present study, we used multiple
echniques like zymography, Western blotting, chromozym TRY
ssay and immuno-ﬂuorescence staining to conﬁrm that serine
rotease is one of the major SM-induced proteases that may  be
esponsible for vescication. In our chromozym TRY substrate assay,
he increase in serine protease activity due to SM was 4 fold higher
ompared to untreated control cell. The chromozym TRY assay can
dentify substrate speciﬁcity, e.g., serine-like proteolysis, and can be
sed to indicate the general class of proteases. However, this assay
annot identify a speciﬁc protease unless more selective reagent is
sed to neutralize protease activity.
Papirmeister et al. [25] proposed a hypothesis of the biochemical
echanism of skin blistering due to SM via protease stimulation.MT-MMP-1 mRNA levels (% of control) and standard error bars are from determi-
nations using 8 separate samples.
This hypothesis was as follows. SM being a strong bifunctional
alkylating compound induces DNA double strand breaks in cells
exposed to SM.  This DNA damage causes the activation of the DNA
repair enzyme poly (ADP ribose) polymerase (PARP), which uti-
lizes NAD+ (nicotinamide adenine dinucleotide) as its substrate
and as such cellular NAD is depleted. Since NAD is also required
as a cofactor for cellular energy metabolism, its depletion causes
hexose monophosphate shunt metabolic pathway stimulation and
consequently protease activation and release. Another possible
mechanism of SM-induced protease stimulation has been pro-
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osed to be related to an increase in intracellular free calcium
on concentration due to SM [13], which may  activate calcium-
ependent enzymes like phospholipases and/or proteases [26]. The
ajor target of SM in the skin are the replicating basal epider-
al  keratinocytes, which remain attached to the sub epithelial
ayer (dermis) via some attachment proteins e.g., laminin-5, inte-
rin etc. Protease activation and release at this epidermal-dermal
unction degrades these attachment proteins and as a consequence
he epithelial layer detaches from the substratum and eventually
icro blister formation [27]. The above discussion suggests that
M-induced protease activation may  contribute to the pathology of
lister formation; therefore, inhibitors of SM-stimulated proteases
ay  serve as prospective therapeutics for intervention for sulfur
ustard toxicity.
Matrix metalloproteases (MMPs) are a family of zinc-dependent
nzymes that are primarily responsible for the degradation of
xtracellular matrix proteins [28,29]. These enzymes are secreted
s zymogens and cleaved to their active forms by other enzymes in
he extracellular space. Gelatinolytic activity of MMP-9 was  up-
egulated by cytokine (for example, TNF-) in both soluble and
mmobilized forms. However, MMP-2 was secreted in pro-active
orm and only activated by interaction with membrane-type MT-
MPs associated to the cell surface [30–32]. In previous reports
n MMPs only a few were implicated in laminin-5 processing.
xogenous addition of matrix metalloprotease 2 (MMP-2) to breast
pithelial cells, cleaved the 2 subunit of rat laminin-5 [33]. A
ubsequent study suggested that membrane type 1 matrix met-
lloprotease (MT1-MMP) may  play a role in cleaving laminin-5
31]. One report indicated that matrix metalloprotease-2 and -9 are
nvolved in blistering induced by SM or nitrogen mustard [9]. They
lso found that there was a greater increase in MMP-9 (92 kDa)
han in MMP-2 (72 kDa) induced by SM intoxication [9]. In the
resent study, the western blot results indicated that among the
atalloproteases, the membrane type 1 MMP  (MT-MMP-1, 64 kDa)
as most likely involved in the vesication processes. MT1-MMP
as been described as a major activator of MMP-2 [34], but MT1-
MP  also possesses the ability to degrade extracellular component,
ncluding gelatin, ﬁbronectin, collagen, and laminin-5 [35,36]. From
estern blotting it appeared that MT-MMP-1 was increased and
MP-9 was decreased after SM exposure (Fig. 6). MT-MMP-1 and
MP-9 were almost eliminated by pretreatment of the metallo-
rotease inhibitor, amastatin 30 min  prior to SM exposure; this
ndicated that the MT-MMP-1 and MMP-9 were sensitive proteases
or the amastatin’s inhibitory effect. The reason for this drastic
eduction of MT-MMP-1 and MMP-9 in cells pretreated with amas-
atin and then exposed to SM remains to be investigated. These
esults were consistent with our ﬁndings by zymography that the
4 kDa protease was increased and the increase was blocked by
etalloprotease inhibitor, amastatin. These results supported the
dea that MT-  MMP-1 could be one important enzyme induced or
ctivated by SM exposure. It is also known that some serine pro-
eases can release matrix metalloprotease, MMP-2 from human
ascular smooth muscle cells and can stimulate the conversion of
ro-MMP-2 to MMP-2 [32]. The relationship between serine pro-
ease and MMP-2 remains to be clariﬁed.
The basement membrane between the epidermis and the der-
is  contains unique
structural proteins that maintain the attachment of the two
ayers one of the key components of the anchoring complex is
aminin-5 [3]. It has been postulated that (a) laminin-5 directly
inds to type VII collagen, which forms the anchoring ﬁbrils that
nsert into the papillary dermis [37]; and (b) laminin-5 forms a
ovalent complex with laminin-6 or -7 and this laminin 5–6/7
omplex interacts with type IV collagen in the basement mem-
rane [38]. It has also been reported that laminin-5 cleavage by
MPs may  be a wide spread mechanism that triggers migrationrts 3 (2016) 393–400 399
of cells contacting basement membranes [39]. Our study demon-
strated that laminin-5 was degraded after SM exposure and the
degradation of laminin-5 was  reduced by metalloprotease inhibitor
or serine protease inhibitor. An intact basement membrane at the
dermal-epidermal junction is essential to the viability of the skin
and in the process of communications between the dermis and the
epidermis [39].
In conclusion, based on the ﬁndings presented here from our
experiments using the in vitro NHEK model of SM toxicity, we pro-
pose a working hypothesis of the SM-induced skin vesication as
follows. SM exposure may  stimulate multiple proteases to include
serine protease and metalloprotease in the basal epidermal ker-
atinocytes (NHEK). These proteases are released at the basement
membrane zone (BMZ) i.e., the epidermal-dermal junction and
degrade the epidermal-dermal attachment proteins e.g., laminin-5,
which is one of the anchoring ﬁlaments responsible for maintain-
ing the BMZ  integrity. As a result, the epidermal layer gets detached
from the dermis causing a separation of the epidermis from the
dermis; this triggers a hydrodynamic effect at the site of the sepa-
ration and, thus, the formation of a ﬂuid ﬁlled blister or vesication.
The fact that protease inhibitors like aprotinin or amastatin atten-
uate protease stimulation and laminin-5 degradation suggest their
prospect for application as a medical countermeasure for SM vesi-
cation. However, since these concepts are derived from an in vitro
model, these need to be validated in vivo in an appropriate animal
skin vesication model such as the hairless guinea pig skin and/or
the mouse ear.
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